Leveraging current momentum to accelerate omni-channel maturity in Health Science

Tuesday 12th May 2020
1pm – 2pm PDT


Over the last few years HCP engagement preferences have evolved significantly, proving the reliance on face-to-face sales models ineffective – a challenge further amplified by the restraints associated with COVID-19.

While the disruption at hand is very real, it has also accelerated the need for change. Health Science organisations in particular, are faced with a unique opportunity to leverage the current momentum and fast-track their omni-channel maturity.

So, what does best-practice look like and how do you get there?

Join us on 12 May as we explore:

  • Common barriers preventing a digital approach
  • The impact COVID-19 has had on the sector
  • Key benefits of omni-channel and lessons learnt from other industries
  • A proven framework and the implementation principles which determine success


Marty Nicholas

Managing Director

Matt McLaren

Vice President, Americas 

Alysia Halloway

Business Unit Head, Women’s
Health & Established Products
Bayer Pharmaceuticals